CANNAPHARMARX, INC. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
CANNAPHARMARX, INC. (CPMD) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-10.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2025-04-10
- CANNAPHARMARX, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- CANNAPHARMARX, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $117.00K.
- CANNAPHARMARX, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was $0.00.
- CANNAPHARMARX, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $0.00.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-04-10 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-06-25 | ||
| 2023-12-31 | $0.00 10-K · filed 2025-04-10 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | ||
| 2023-03-31 | $117.00K 10-Q · filed 2024-06-25 |